Shares of Agilent Technologies (A) Sees Large Inflow of Net Money Flow

Agilent Technologies (A): $1.42 million was the positive money flow into the stock on Wednesday and the up/down ratio of ticks was also in favor of the bulls at 2.11. The value of trades done on upticks was $2.69 million, whereas, trades done on downticks were valued at $1.28 million. Money flows are calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades. large traders, also sometimes called as the smart money, block traded $1.16 million worth stocks on upticks, which is a bullish indication. The money flow in block trades was $1.16 million. Agilent Technologies (A) fell $0.04 traded at $46.66, a change of -0.09% over the previous day. The stock is 0.11% for the week.


Shares of Agilent Technologies, Inc. appreciated by 2.48% during the last five trading days but lost 0.92% on a 4-week basis. Agilent Technologies, Inc. is up 8.1% in the last 3-month period. Year-to-Date the stock performance stands at 13.47%.

Agilent Technologies (A) : Zacks Investment Research ranks Agilent Technologies (A) as 3, which is a Hold recommendation. 5 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 3 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 8 research analysts is 1.75, which indicates as a Buy.

Agilent Technologies (NYSE:A): The stock opened at $46.9 and touched an intraday high of $47.26 on Wednesday. During the day, the stock corrected to an intraday low of $46.52, however, the bulls stepped in and pushed the price higher to close in the green at $47.18 with a gain of 1.03% for the day. The total traded volume for the day was 1,502,533. The stock had closed at $46.7 in the previous trading session.

Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.